UPDATE - UBS Upgrades Amdocs Ltd. (DOX) to Buy; Continued Favorable Mix Shift: Emerging Markets, Managed Services
Tweet Send to a Friend
UPDATE - UBS upgrades Amdocs Ltd. (NYSE: DOX) from Neutral to Buy. PT increased from $30 to $33.
UBS analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
